Disposition of antigen-presenting liposomes in vivo: effect on presentation of herpes simplex virus antigen rgD.

[1]  H. Spits,et al.  IL-1, IL-4, and IFN-gamma differentially regulate cytokine production and cell surface molecule expression in cultured human thymic epithelial cells. , 1991, Journal of immunology.

[2]  T. Merigan,et al.  Physical and biological characterization of antigen presenting liposome formulations: relative efficacy for the treatment of recurrent genital HSV-2 in guinea pigs. , 1990, Antiviral research.

[3]  P. Artursson,et al.  Microparticles as potentially orally active immunological adjuvants. , 1989, Vaccine.

[4]  T. Merigan,et al.  Antigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs , 1989, Journal of virology.

[5]  D. Bernstein,et al.  Herpes simplex virus glycoprotein immunotherapy of recurrent genital herpes: factors influencing efficacy. , 1989, Antiviral research.

[6]  G. Ott,et al.  The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine. , 1988, Journal of immunology.

[7]  L. Lasky,et al.  Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs. , 1988, The Journal of infectious diseases.

[8]  D. Bernstein,et al.  Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. , 1987, The Journal of infectious diseases.

[9]  J. Rooney,et al.  Acquisition of genital herpes from an asymptomatic sexual partner. , 1986, The New England journal of medicine.

[10]  L. Corey,et al.  Infections with herpes simplex viruses (1). , 1986, The New England journal of medicine.

[11]  S. Knight,et al.  Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[12]  B. Rouse,et al.  Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes , 1980, Infection and immunity.

[13]  D. Dunn,et al.  CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERS , 1979, The Lancet.

[14]  R. Steinman,et al.  Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen , 1975, The Journal of experimental medicine.

[15]  T. F. Scott.  Infection with herpes simplex virus. , 1955, GP.

[16]  M. Feldmann,et al.  Granulocyte-macrophage colony stimulating factor induces both HLA-DR expression and cytokine production by human monocytes. , 1990, Cytokine.

[17]  J. Eldridge,et al.  Biodegradable microspheres: vaccine delivery system for oral immunization. , 1989, Current topics in microbiology and immunology.

[18]  L. Stanberry,et al.  Herpes simplex virus glycoprotein treatment of recurrent genital herpes. , 1988, The Journal of infectious diseases.

[19]  D. Baker,et al.  Phenotypic analysis of guinea pig Langerhans cells with antibodies directed against leucocyte surface antigens. , 1988, International archives of allergy and applied immunology.